Results 31 to 40 of about 586,644 (327)

Cost-Effectiveness of Physical Rehabilitation and Care of Older Home-Dwelling Persons after Hip Fracture: A Systematic Review and Narrative Synthesis

Journal of Rehabilitation Medicine, 2022
Objective: To provide a systematic review of the literature and knowledge base of cost per quality-adjusted life year of physical rehabilitation and care of older persons after hip fracture.
Jonas Ammundsen Ipsen, Lars T. Pedersen, Eva Draborg , Inge H. Bruun, Charlotte Abrahamsen , Bjarke Viberg   +5 more
doaj   +1 more source

The application of the QALY measure in the assessment of the effects of health interventions on an older population: a systematic scoping review

Archives of Public Health, 2021
Background One of the most commonly used types of evaluation methods is cost-utility analysis (CUA), using the Quality Adjusted Life Year (QALY) indicator as a preference-based measure for assessing effects of a given programme.
Ewa Kocot, Paulina Kotarba, Katarzyna Dubas-Jakóbczyk   +2 more
doaj   +1 more source

Income-related inequality in life-years and quality-adjusted life-years [PDF]

Journal of Health Economics, 2000
We estimate the income-related inequality in Sweden with respect to life-years and quality-adjusted life-years (QALYs). We use a large data set from Sweden with over 40,000 individuals followed up for 10-16 years, to estimate the survival and quality-adjusted survival in different income groups.
Gerdtham, Ulf-G., Johannesson, Magnus
openaire   +4 more sources

Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19.

Health Economics, 2020
Many epidemiological models of the COVID-19 pandemic have focused on preventing deaths. Questions have been raised as to the frailty of those succumbing to the COVID-19 infection.
A. Briggs, D. Goldstein, E. Kirwin, R. Meacock, A. Pandya, D. Vanness, T. Wisløff   +6 more
semanticscholar   +1 more source

Sequencing Systemic Therapy Pathways for Advanced Hepatocellular Carcinoma: A Cost Effectiveness Analysis

Liver Cancer, 2020
Introduction: Hepatocellular carcinoma (HCC) is the most common form of liver cancer worldwide and carries a poor prognosis. Historically, sorafenib was the only available systemic treatment for advanced HCC.
Christopher Sherrow, Kristopher Attwood, Kehua Zhou, Sarbajit Mukherjee, Renuka Iyer, Christos Fountzilas   +5 more
doaj   +1 more source

The effect of surfactant type on characteristics, skin penetration and anti-aging effectiveness of transfersomes containing amniotic mesenchymal stem cells metabolite products in UV-aging induced mice

Drug Delivery, 2022
Transfersome has been developed to enhance dermal delivery of amniotic mesenchymal stem cell metabolite products (AMSC-MP). AMSC-MP contains many growth factors for managing skin aging, thus improving the quality of an adjusted life year. This study aims
Andang Miatmoko, Nurul Ailda Marufah, Qothrin Nada, Noorma Rosita, Tristiana Erawati, Joni Susanto, Kusuma Eko Purwantari, Arif Nurkanto, Purwati  , Widji Soeratri   +9 more
doaj   +1 more source

New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year. [PDF]

Eur J Health Econ, 2018
Attema AE, Krol M, van Exel J, Brouwer WBF.   +3 more
europepmc   +3 more sources

Methods to Estimate Willingness-to-Pay Per Quality Adjusted Life Year as Cost-Effectiveness Threshold

Jurnal Manajemen dan Pelayanan Farmasi, 2018
Pharmacoeconomic studies, especially the cost-utility analysis method, require a cost-effectiveness threshold for interpretation of the cost-effectiveness ratios of the study. The cost-effectiveness threshold is determined by each country.
Tri Murti Andayani, Dwi Endarti, Susi Ari Kristina, Rifqi Rokhman   +3 more
doaj   +1 more source

Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies

Фармакоэкономика, 2018
The aim was to develop a methodology for determining the willingness to pay threshold (WTPT) and its upper limit value within the Russian health care system.Materials and methods. WTPT was calculated based on the shadow budget price (i. e.
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov   +5 more
doaj   +1 more source

The Estimate of Parental Quality of Life Loss Due to Respiratory Syncytial Virus (RSV) Hospitalization

Diseases, 2023
Background: Respiratory syncytial virus (RSV) is one of the leading causes of pediatric hospitalizations, mainly in children under 2 years of age. Hospitalization affects the caregivers’ quality of life (QoL).
August Wrotek, Oliwia Wrotek, Teresa Jackowska   +2 more
doaj   +1 more source